What a saga and disaster driven management both for TIS before and FTT later.
It was not enough for this management the fact that they killed this company in years made of capital raising, consultants paid, clinical trials failing. Now as a defense pill they raise capital from a company in ashes.
I do not know, but so much failure is visible here, that at this stage maybe would be better a shakeup with cash than a dilution that does not make any sense.
Provide us the truth, not this bullshit.
NO, NO, NO a capital raise at this horrible terms.
Walk away management!
FTT Price at posting:
0.3¢ Sentiment: None Disclosure: Held
